Status:
COMPLETED
Metabolomic Analysis of Lung Cancer
Lead Sponsor:
University of Louisville
Collaborating Sponsors:
James Graham Brown Cancer Center
Conditions:
Carcinoma, Non-Small Cell Lung
Carcinoma, Small Cell Lung
Eligibility:
All Genders
18-75 years
Brief Summary
The purpose of this study is to learn more about the metabolic properties of lung cancer cells.
Detailed Description
It has long been known that cancer cells absorb and break down substances in the body differently than healthy, non-cancer cells. This process of absorbing and breaking down substances is known as met...
Eligibility Criteria
Inclusion
- Lung Cancer Patients (Groups 1 \& 2)
- patients with suspected, clinically diagnosed, or histologically diagnosed lung cancer. Occasionally, other cancers (including metastatic cancers to the lung) may be resected for the study as negative controls for NSCLC, as warranted by the particulars of the case.
- patients must have general medical conditions to allow them to undergo surgical resection of their primary tumor
Exclusion
- history of diabetes for the experimental group (surgery + glucose); patients with a history of diabetes are allowed in the control group (surgery/no glucose)
- known hepatitis C or HIV (AIDS)
- Healthy Subjects (Group 3)
- Inclusion Criteria:
- at least 30 years of age
- preferably be fasting for 12 hours (minimum 8 hours) prior to enrollment
Key Trial Info
Start Date :
December 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 24 2020
Estimated Enrollment :
249 Patients enrolled
Trial Details
Trial ID
NCT00263731
Start Date
December 1 2005
End Date
September 24 2020
Last Update
May 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
James Graham Brown Cancer Center, University of Louisville
Louisville, Kentucky, United States, 40202